BiotechTube

Abametapir Lotion 0.74% w/w + Sodium Lauryl Sulfate + Saline 0.9% + Placebo

Phase 1Completed
0 watching 0 views this week💤 Quiet
30
Hype Score

Development Stage

✓
Pre-clinical
2
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Head Lice

Conditions

Head Lice

Trial Timeline

Jan 1, 2014 → May 1, 2014

NCT ID
NCT02061813

About Abametapir Lotion 0.74% w/w + Sodium Lauryl Sulfate + Saline 0.9% + Placebo

Abametapir Lotion 0.74% w/w + Sodium Lauryl Sulfate + Saline 0.9% + Placebo is a phase 1 stage product being developed by Dr. Reddy's Laboratories for Head Lice. The current trial status is completed. This product is registered under clinical trial identifier NCT02061813. Target conditions include Head Lice.

Hype Score Breakdown

Clinical
10
Activity
5
Company
7
Novelty
3
Community
2

Clinical Trials (1)

NCT IDPhaseStatus
NCT02061813Phase 1Completed

Competing Products

20 competing products in Head Lice

See all competitors
ProductCompanyStageHype Score
AFM24 + SNK01AffimedPhase 1/2
33
Cemiplimab + CetuximabEli LillyPhase 2
52
BB-401Benitec BiopharmaPhase 2
44
Placebo + LY2300559Eli LillyPhase 2
52
Gemcitabine + ACR-368Acrivon TherapeuticsPhase 2
44
Ketorolac + Prochlorperazine + DiphenhydramineAssertio HoldingsPhase 2
44
Ramucirumab + PembrolizumabEli LillyPhase 2
52
Ozuriftamab Vedotin + Pembrolizumab + Evalstotug (BA3071) + CetuximabBioAtlaPhase 2
44
Patritumab + Cetuximab + Cisplatin + Carboplatin + PlaceboDaiichi SankyoPhase 2
52
Patritumab + Cetuximab + Cisplatin + CarboplatinDaiichi SankyoPhase 1
33
cevimeline hydrochlorideDaiichi SankyoPhase 3
77
Docetaxel + Erlotinib + ChemotherapyAstellas PharmaPhase 2
52
ErlotinibAstellas PharmaPhase 1
33
avelumab + Bempegaldesleukin + talazoparib + enzalutamideAstellas PharmaPhase 1/2
41
Ivermectin Lotion, 0.5% + SKLICE (ivermectin) Lotion, 0.5% + Vehicle of the Test productSun PharmaceuticalPhase 1
33
Drug Combination TherapySun PharmaceuticalPhase 2
52
Lenvatinib + Pembrolizumab + Docetaxel + Capecitabine + Paclitaxel + Cetuximab + LenvatinibEisaiPhase 2
52
E7050 + CetuximabEisaiPhase 1/2
41
Lenvatinib + Pembrolizumab + PlaceboEisaiPhase 3
77
Lenvatinib + Pembrolizumab + PlaceboEisaiPhase 3
77

Other Products from Dr. Reddy's Laboratories

OMEZ 40 + OMEZ 80Approved
82
Ketorolac Tromethamine + KetoprofenApproved
82
omeprazole+domperidone SR + omeprazoleApproved
82
NISEApproved
82
Levofloxacin + LevofloxacinApproved
82